Insulin Glargine vs Nivolumab

## Insulin Glargine vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Insulin Glargine** and **Nivolumab**.

## Mechanism of Action

**Insulin Glargine**: Long-acting insulin analogue that binds insulin receptors.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Insulin Glargine — 12-24 hours; Nivolumab — 27 days.

## Chemical Properties

**Type**: Insulin Glargine — Protein; Nivolumab — Antibody.